Oral Manifestations and Salivary pH Changes in Children undergoing Antineoplastic Therapy

Leila Maues Oliveira Hanna, Maria Teresa Santos Rodrigues Botti, Rodolfo Jose Gomes de Araujo, Jessica Mendes Damasceno, Andressa Soraia Barros Mayhew

Abstract


Objective: To identify the oral manifestations and salivary pH before and after chemotherapy in pediatric patients. Material and Methods: The sample consisted of 46 children. It was included children from 2 to 12 years, diagnosed with Acute Lymphoblastic Leukemia (ALL) and they would be subjected to chemotherapy. The first evaluation was performed before chemotherapy and consisted of anamnesis, oral clinical examination and saliva collection to measure the pH. The second evaluation was performed among 10 to 15 days after the start of chemotherapy treatment and consisted of new saliva collection and clinical examination. Results: The results showed that the gender most affected by childhood cancer was male. The predominant age group were children aged 8-12 years. The most frequent oral manifestations were mucositis (35%), xerostomia (26%), toothache and dysphagia (22%). There was also a significant reduction in salivary pH after chemotherapy, p <0.0001, indicating that the average pre and post chemotherapy are different (Δ = 10.6) with statistical significance at the 5% level. Conclusion: Patients with ALL can present any lesion in the oral cavity during or after the start of chemotherapy and undergo changes in the amount of salivary pH. The dentist needs and know the oral manifestations and intervene in the oral health of patients with ALL, contributing and assisting in their treatment.


Keywords


Cancer Patients; Chemotherapy; Oral Manifestations.

Full Text:

PDF

References


Morais EF, Lira JAS, Macedo RAP, Santos KS, Elias CTV, Arruda-Morais MLS. Oral manifestations resulting from chemotherapy in children with acute lymphoblastic leukemia. Braz J Otorhinolaryngol 2014; 80:78-85.

Berger Velten D, Zandonade E, Monteiro de Barros Miotto MH. Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy. BMC Oral Health 2016; 16(1):107.

Martins ACM, Caçador NP, Gaeti WP: Complicações bucais da quimioterapia antineoplásica. Acta Sci 2002; 4(3):663-670.

Thomaz EBAF, Mouchrek JCE Jr, Silva AQ, Guerra RNM, Libério SA, Cruz MCFN: Longitudinal assessment of immunological and oral clinical conditions in patients undergoing anticancer treatment for leukemia. Int J Pediatr Otorhinolaryngol 2013; 77:1088-93.

Abreu LMG, Lopes FF, Pereira AFV, Pereira ALA, Alves CMC. Doença periodontal e condições sistêmicas: mecanismos de interação. Rev Pesq Saúde 2010; 11(2):52-6.

Mendonça R, Guerreiro LA, Cappellaro K, Pinheiro VRP, Lopes MA. Oral lesions associated with hydroxyurea treatment. Indian J Dent Res 2011; 22(6):869-70.

Xu L, Zhang H, Liu J, Chen X. Investigation of the oral infections and manifestations seen in patients with advanced câncer. Pak J Med Sci 2013; 29(5):1112-5.

Organização Mundial da Saúde. Levantamentos básicos em saúde bucal. Sao Paulo: Santos; 1997.

Estrela C. Metodologia científica. São Paulo : Artes Médicas, 2005.

Figueiredo PBA, Nogueira AJS. Prevalência de neoplasias, cárie e gengivite em pacientes oncológicos pediátricos no município de Belém, Pará. Pes Bras Odontoped Clin Integr 2013; 13(2):141-6.

Barbosa AM, Ribeiro DM, Coldo-Teixeira AS. Conhecimentos e práticas em saúde bucal com crianças hospitalizadas com câncer. Ciência & Saúde Coletiva 2010; 15(1):1113-22.

Frappaz D, Vasiljevic A, Beuriat PA, Alapetite C, Grill J, Szathmari A, Faure-Conter C. Pediatric ependymomas: Current diagnosis and therapy. Bull Cancer 2016; 103(10):869-79.

Mendonça RM, Araújo M, Levy CE, Morari J, Silva RA, Yunes JA. Prospective evaluation of HSV, Candida spp., and oral bacteria on the severity of oral mucositis in pediatric acute lymphoblastic leukemia. Support Care Cancer 2012; 20:1101-7.

Volpato LE, Kloster AP, Nunes LF, Pedro FL, Borges AH. Cariogenic microbiota of children under chemotherapy: A pilot study. J Indian Soc Pedod Prev Dent 2016; 34(4):370-6.

López ME, Colloca ME, Paez RG, Schallmach N, Koss MA. Chernonagura A. Salivary characteristics oh diabetic children. Braz Dent J 2003; 14(1):26-31.

Soares AF, Aquino ARL, Carvalho CHP, Nonaka CFW, Almeida D, Pinto LP. Frequency of oral mucositis and microbiological analysis in children with acute lymphoblastic leukemia treated with 0.12% chlorhexidinegluconate. Braz Dent J 2011; 22:312-6.

Torres EP, Ruíz MSR, Alejo GF, Hernández SJF, Pozos GAJ. Oral manifestations in pediatric patients receiving chemotherapy for acute lymphoblastic leukemia. J Clin Pediatr Dent 2010; 34:275-80.

Pels E, Mielnik BM. Oral hygiene in children suffering from acute lymphoblastic leukemia living in rural and urban regions. Ann Agric Environ Med 2012; 19: 529-33.

Morais EF, Lira JAS, Macedo RAP, Santos KS, Elias CTV, Arruda-Morais MLS. Manifestações orais decorrentes da quimioterapia em crianças portadoras de leucemia linfocítica aguda. Braz J Otorhinolaryngol 2014; 80(1):78-85.

Silva RHA, Castro RFM, Bastos JRM, Camargo LMA. Análise das diferentes manifestações de cultura quanto aos cuidados em saúde bucal em moradores de região rural ribeirinha em Rondônia, Brasil. Ciência & Saúde Coletiva 2010; 15 (Supl. 1):1475-80.

Kang MS, Jong-Suk O, Jeong KY, Kim HJ, Lee JJ, Lee GS, Lim HJ, LimHS. Analysis of cariogenic bacteria in saliva of cancer patients. Chonnam Med J 2013; 49(2):75-80.

Santos TFR, Coradini CDB, Ribeiro DM, Angela Scarparo Caldo-Teixeira AS. Knowledge and practice of oral health in child patients with cancer. Arq Odontol 2010; 46(1):5-10.

Alamoudi N, Farsi N, Faris J, Masoud I, Merdad K, Meisha D. Salivary characteristics of children and its relation to oral microorganis, and lip mucosa dryness. J Clin Pediatr Dent 2004; 28(3):239-48.

Hollingsworth B, Senter L, Zhang X, Brock GN, Jarjour W, Nagy R, Brock P, Coombes KR, Kloos R, Ringel MD, Sipos J, Lattimer I, Carrau R, Jhiang SM. Risk factors of 131i-induced salivary gland damage in thyroid cancer patients. J Clin Endocrinol Metab 2016; 101(11):4085-93.




PBOCI IS A MEMBER OF CROSSREF AND ALL THE CONTENT OF ITS JOURNALS ARE LINKED BY DOIS THROUGH CROSSREF.